Metagenomi: Q2 Earnings Snapshot

Audio By Carbonatix

EMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Metagenomi Inc. (MGX) on Wednesday reported a loss of $10.7 million in its second quarter.

On a per-share basis, the Emeryville, California-based company said it had a loss of 29 cents.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.

The genetic medicines company posted revenue of $20 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $14.8 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGX at https://www.zacks.com/ap/MGX